A randomized, double-blind, placebo-controlled, multi-center, parallel group study to assess the efficacy of vardenafil in the treatment of subjects with symptomatic benign prostatic hyperplasia.

Trial Profile

A randomized, double-blind, placebo-controlled, multi-center, parallel group study to assess the efficacy of vardenafil in the treatment of subjects with symptomatic benign prostatic hyperplasia.

Completed
Phase of Trial: Phase II

Latest Information Update: 13 Jan 2014

At a glance

  • Drugs Vardenafil (Primary)
  • Indications Benign prostatic hyperplasia
  • Focus Therapeutic Use
  • Sponsors Bayer
  • Most Recent Events

    • 29 Aug 2012 New source identified and integrated (German Clinical Trials Register; DRKS00004050).
    • 12 Jul 2011 New source added and integrated (European Clinical Trials Database, EudraCT2005-002796-32).
    • 01 Jun 2008 Results have been published in European Urology.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top